Navigation Links
Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol

Researchers at The University of Texas M. D. Anderson Cancer Center have developed a way to test whether the new targeted therapy Tarceva and the widely used chemotherapy drug Taxol are effectively killing tumor cells. They say that with further refinement, the test may make it possible to accurately assess whether patients are responding to these agents, as well as potentially others, within days of beginning therapy.

In two different studies being presented at the annual meeting of the American Association for Cancer Research (AACR), the research team will describe how the test measures the activity of several members of the cyclin-dependent kinase (CDK) family of enzymes, which are the triggering molecules that allow a cell to grow and divide. CDK cell cycle enzymes are the end target of numerous cellular pathways that are involved in cancer development and progression, the researchers say.

Before these studies, no one has been able to accurately test the function of enzymes from a tumor sample, says Naoto Ueno, M.D., Ph.D., an associate professor in the Breast Cancer Translational Research Laboratory and the Department of Blood and Marrow Transplantation.

"Testing CDK only has been possible by measuring gene expression, but our industry collaborator has provided a way that lets us test real enzyme activity within a human tumor sample," he says. "Our hope is to be able to use this system as a molecular marker to assess whether an anti-cancer therapy is working."

ABSTRACT # 1670

Sensitivity to Tarceva Depends on CDK2

In the first study, M. D. Anderson researchers found that loss of the CDK2 enzyme strongly correlated with a cancer's sensitivity to Tarceva.

That means testing activity of CDK2, the enzyme that drives cell division, can reveal whether or not a tumor will respond to Tarceva, says Naoto Ueno, M.D., Ph.D., an associate professor in the Breast Cancer Translational Research Laboratory and the Departm
'"/>

Source:University Of Texas M. D. Anderson Cancer Center


Page: 1 2 3

Related biology news :

1. Measuring the impact of post-genomics on Mediterranean populations
2. Measuring hormone cuts antibiotic use in half in pneumonia patients
3. Measuring hidden parasites in falciparum malaria
4. Measuring artery repair cells could become new heart disease test
5. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
6. Jump-starting T Cells In Skin Cancer
7. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
8. Fox Chase Cancer Center scientists identify immune-system mutation
9. Breakthrough Microarray-based Technology for the Study of Cancer
10. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
11. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
Post Your Comments:
(Date:9/30/2014)... threats in today,s ocean. From overfishing and pollution ... ecosystems are disappearing at unprecedented rates around the ... surrounding the island of Moorea in French Polynesia ... coral guard-crabs. New research from the National Museum ... McKeon and the museum,s predoctoral fellow Jenna Moore ...
(Date:9/29/2014)... the exposure to tar tended to be lower for ... Similarly, exposure to nicotine tended to be lower. , ... in several countries around the world. Previous studies have ... the smoke of these cigarettes are lower than those ... in the smoke are not necessarily linked to a ...
(Date:9/29/2014)... in school? According to a new Food and Brand ... meals can increase participation in the National School Lunch ... of vegetables by 16%! , Chefs Move to Schools ... pairs chefs with schools in order to provide nutrition ... food service workers. , A CMTS event was held ...
Breaking Biology News(10 mins):Smithsonian scientists discover coral's best defender against an army of sea stars 2Slim cigarette smokers not exposed to more harmful chemicals 2Chefs move to schools can increase school meal participation and vegetable intake among students 2
... , This release is available in German . ... chemically fix, stain or cut cells in order to study them. ... environment. The new method delivers an immediate 3-D image, thereby closing ... a high-resolution 3-D image of the entire cell in one step. ...
... Mass. Although people infected with HIV produce many antibodies ... are strangely ineffective at fighting the disease. A new study ... don,t work: they target the protein in a form it ... it,s too late, report researchers at Children,s Hospital Boston and ...
... Madrid, Friday November 19th, 2010. It is estimated ... / 10,000 people- affect about 6% of the European population. ... risk of having a newborn with a severe syndrome of ... affected by one of these diseases, being the most common ...
Cached Biology News:New microscope reveals ultrastructure of cells 2Designing more effective anti-HIV antibodies 2Designing more effective anti-HIV antibodies 3Spain is leading the fight against rare anemias in Europe 2
(Date:9/30/2014)... 30, 2014  RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ... has received a Canadian Patent for Inhibition or ... patent includes claims using thymosin beta 4, various ... for these purposes.  The patent will expire in ... ( www.regenerx.com ) RegeneRx is ...
(Date:9/30/2014)... 30, 2014 Fast, semi-automatic ... chemistry in documents ChemAxon , ... consulting services for life science research, launches ChemCurator, ... Markush structures from documents. Markush structures ... however generating and understanding Markush structures is a ...
(Date:9/30/2014)... 2014 OriginOil Inc. (OTC/QB: OOIL), developer ... to clean up large quantities of water, announced today ... reported on the launch of the company's CLEAN-FRACâ„¢ industrial ... by partner STW Resources . , Immediately upon ... day (bpd) and achieved a 99.8% reduction in Turbidity ...
(Date:9/30/2014)... Md., Sept. 30, 2014 BioHealth Innovation, ... commercializing market-relevant biohealth innovations and increasing access to early-stage ... today that venture capitalist, Tania Fernandez , Ph.D., ... Dr. Fernandez will be a member of the management ... provide up to $50 million in seed and early-stage ...
Breaking Biology Technology:RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2
... LOS ALAMOS, New Mexico, December 13, 2007In collaboration ... Alamos, an international team of researchers has, for ... formation of mysterious metallic puddles that facilitate the ... electrically conducting one. , The research may lead ...
... SAN DIEGO, Dec. 13 Neurocrine Biosciences,Inc. (Nasdaq: ... at its San Diego campus, as a part of ... and associated costs,and expenses after the setback on indiplon. ... "It is with great disappointment that we have to ...
... GRENOBLE France, December 13 ,STALLERGENES S.A and Protein,eXpert ... developing and pharmaceutically producing mites,recombinant allergens(1)., The ... programme for a recombinant protein treatment for sublingual,desensitisation ... up of the recombinant allergens Der p 1 ...
Cached Biology Technology:Collaboration yields 'the right glasses' for observing mystery behavior in electrons 2Collaboration yields 'the right glasses' for observing mystery behavior in electrons 3Neurocrine Announces Work Force Restructuring 2Neurocrine Announces Work Force Restructuring 3STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens 2STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens 3